Trend-Following Backtester · Guide · backtest 한국어

equity · SE

BioArctic AB Class B backtest

10 trend-following strategies were compared on the full daily history of BioArctic AB Class B. 0 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester.

Data 2017-10-12 ~ 2026-07-31daily bars 2,208 (8.8 years)Costs 0.5%Venue OMXSTOMonthly snapshot 2026-07-31

Results by strategy

0 of 10 beat buy and hold (CAGR 31.5%, drawdown -69.4%).

Sharpe leader (same as main): Supertrend — CAGR 20.7%, MDD -68.2%, Sharpe 0.46, 46% exposure.

No strategy retained at least 75% of buy-and-hold CAGR while reducing drawdown by both 20% relatively and 5 percentage points absolutely.

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=23, mult=4.7
20.7%-68.2%0.460.305.2x2646%
SMA 크로스오버
fast=50, slow=74
19.1%-69.2%0.450.284.6x4451%
MACD
fast=13, slow=16, signal=11
17.2%-52.1%0.420.334.0x16350%
ROC 모멘텀
n=67, threshold=-0.01
10.7%-70.7%0.380.152.5x11550%
EMA 크로스오버
fast=57, slow=119
10.2%-66.4%0.380.152.4x1356%
ADX / DI 방향성
period=21, threshold=22
3.8%-45.5%0.280.081.4x3222%
Donchian 채널 돌파
entryN=55, exitN=70
-2.9%-73.2%0.22-0.040.8x2061%
Parabolic SAR
step=0.035, maxStep=0.18
-3.2%-85.4%0.22-0.040.8x24547%
볼린저 밴드 돌파
n=48, k=3.1
1.1%-65.9%0.200.021.1x2422%
Keltner 채널 돌파
emaPeriod=45, atrPeriod=14, mult=3.2
-1.6%-68.2%0.12-0.020.9x2424%
Buy and hold31.5%-69.4%0.570.4511.2x1100%
1x 10x 2018 2020 2022 2024 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -17% -35% -52% -69% 2018 2020 2022 2024 2026 Buy and holdSupertrend
Supertrend maximum drawdown -68.2% (2023-01-17 → 2024-12-18), prior peak not yet recovered.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next